Axsome Therapeutics (AXSM) Gains from Investment Securities (2015 - 2026)
Axsome Therapeutics recorded quarterly Gains from Investment Securities of $6.6 million in Q1 2026, up 533.66% quarter-over-quarter from $1.0 million in Q4 2025, and up 2309.15% year-over-year from $274595.0 in Q1 2025.
Axsome Therapeutics' Gains from Investment Securities history runs 12 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 2309.15% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (up 2309.15% YoY), while the FY2025 annual figure was $7.0 million, down 16.65% from the prior year.
- Gains from Investment Securities came in at $6.6 million for Q1 2026 at Axsome Therapeutics, up from $1.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.0 million in Q1 2023 to a low of $38000.0 in Q4 2023.
- A 5-year average of $2.0 million and a median of $900000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities tumbled 97.97% in 2022 and jumped 11360.53% in 2024, its largest moves.
- Axsome Therapeutics' Gains from Investment Securities stood at $163000.0 in 2022, then sank by 76.69% to $38000.0 in 2023, then surged by 11360.53% to $4.4 million in 2024, then plunged by 76.03% to $1.0 million in 2025, then jumped by 533.66% to $6.6 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $6.6 million, $1.0 million, and $300000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.62 Mn |
| Mar 31, 2026 | 6.62 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 274,595.00 |
| Mar 31, 2025 | 274,595.00 |
| Dec 31, 2024 | 4.36 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 38,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 8.04 Mn |
| Mar 31, 2023 | 8.04 Mn |
| Dec 31, 2022 | 163,000.00 |
| Dec 31, 2022 | 163,000.00 |
| Sep 30, 2022 | 6.54 Mn |
| Sep 30, 2022 | 6.54 Mn |
| Jun 30, 2022 | 111,376.00 |
| Jun 30, 2022 | 111,376.00 |
| Mar 31, 2022 | 89,000.00 |
| Mar 31, 2022 | 89,000.00 |
| Dec 31, 2021 | 91,990.00 |
| Dec 31, 2021 | 91,990.00 |
| Sep 30, 2021 | 4.59 Mn |
| Sep 30, 2021 | 4.59 Mn |
| Jun 30, 2021 | 955,213.00 |
| Jun 30, 2021 | 955,213.00 |
| Mar 31, 2021 | 4.39 Mn |
| Mar 31, 2021 | 4.39 Mn |
| Dec 31, 2020 | 1.62 Mn |
| Dec 31, 2020 | 1.62 Mn |
| Sep 30, 2020 | 642,509.00 |
| Sep 30, 2020 | 642,509.00 |
| Jun 30, 2020 | 28,361.00 |
| Jun 30, 2020 | 28,361.00 |
| Mar 31, 2020 | 2,343.00 |
| Mar 31, 2020 | 2,343.00 |
| Dec 31, 2019 | -29,094.00 |
| Dec 31, 2019 | -29,094.00 |
| Sep 30, 2019 | 3.18 Mn |
| Sep 30, 2019 | 3.18 Mn |
| Jun 30, 2019 | 969,925.00 |
| Jun 30, 2019 | 969,925.00 |
| Mar 31, 2019 | 890,866.00 |
| Mar 31, 2019 | 890,866.00 |
| Dec 31, 2018 | 2.61 Mn |
| Dec 31, 2018 | 2.61 Mn |
| Sep 30, 2018 | 307,925.00 |
| Sep 30, 2018 | 307,925.00 |
| Jun 30, 2018 | 2.91 Mn |
| Jun 30, 2018 | 2.91 Mn |
| Mar 31, 2018 | -2.67 Mn |
| Mar 31, 2018 | -2.67 Mn |
| Dec 31, 2017 | 68,661.00 |
| Dec 31, 2017 | 68,661.00 |
| Sep 30, 2017 | 99,407.00 |
| Sep 30, 2017 | 99,407.00 |
| Jun 30, 2017 | 44,560.00 |
| Jun 30, 2017 | 44,560.00 |
| Mar 31, 2017 | 2.14 Mn |
| Mar 31, 2017 | 2.14 Mn |
| Dec 31, 2016 | 53,696.00 |
| Dec 31, 2016 | 53,696.00 |
| Sep 30, 2016 | 786,654.00 |
| Sep 30, 2016 | 786,654.00 |
| Jun 30, 2016 | 762,372.00 |
| Jun 30, 2016 | 762,372.00 |
| Dec 31, 2015 | 12,062.00 |
| Dec 31, 2015 | 12,062.00 |
| Sep 30, 2015 | 32,005.00 |
| Sep 30, 2015 | 32,005.00 |
| Jun 30, 2015 | -16,572.00 |
| Jun 30, 2015 | -16,572.00 |
| Mar 31, 2015 | -870.00 |
| Mar 31, 2015 | -870.00 |